Chronic obstructive pulmonary disease, or COPD, is one of the world’s leading causes of death, responsible for 3.5 million ...
The European Medicines Agency (EMA) has released a new guideline on clinical trials conducted to assess chronic obstructive pulmonary disease (COPD) products, updating an existing guideline regulators ...
Please provide your email address to receive an email when new articles are posted on . Among both women and men with COPD, less than 50% received maintenance inhaler therapy. Less than 70% received ...
These findings follow previously announced positive top-line results from two other global Phase 3 clinical studies, OBERON (NCT05166889) and TITANIA (NCT05158387), showing that tozorakimab at a ...
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
AJMC®: The 2025 update of the GOLD Report (Global Initiative for Chronic Obstructive Lung Disease Global Strategy for Prevention, Diagnosis and Management of COPD) (GOLD 2025) recommends the ...
Chronic obstructive pulmonary disease, or COPD, caused 141,733 deaths in the United States in 2023 – the latest data that has been reported. That number reflects not just the effects of smoking, but a ...